Login to Your Account



Appointments and Advancements


Tuesday, November 20, 2012
• Blueprint Medicines, of Cambridge, Mass., appointed Chris Varma president and CEO, and named Daniel S. Lynch executive chairman of its board.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription